A Scoping Review Exploring Access to Survivorship Care for Childhood, Adolescent, and Young Adult Cancer Survivors: How Can We Optimize Care Pathways?

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

A Scoping Review Exploring Access to Survivorship Care for Childhood, Adolescent, and Young Adult Cancer Survivors : How Can We Optimize Care Pathways? / McLoone, Jordana K; Sansom-Daly, Ursula M; Paglia, Alexia; Chia, Jessica; Larsen, Hanne Bækgaard; Fern, Lorna A; Cohn, Richard J; Signorelli, Christina .

I: Adolescent health, medicine and therapeutics, Bind 14, 2023, s. 153-174.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

McLoone, JK, Sansom-Daly, UM, Paglia, A, Chia, J, Larsen, HB, Fern, LA, Cohn, RJ & Signorelli, C 2023, 'A Scoping Review Exploring Access to Survivorship Care for Childhood, Adolescent, and Young Adult Cancer Survivors: How Can We Optimize Care Pathways?', Adolescent health, medicine and therapeutics, bind 14, s. 153-174. https://doi.org/10.2147/AHMT.S428215

APA

McLoone, J. K., Sansom-Daly, U. M., Paglia, A., Chia, J., Larsen, H. B., Fern, L. A., Cohn, R. J., & Signorelli, C. (2023). A Scoping Review Exploring Access to Survivorship Care for Childhood, Adolescent, and Young Adult Cancer Survivors: How Can We Optimize Care Pathways? Adolescent health, medicine and therapeutics, 14, 153-174. https://doi.org/10.2147/AHMT.S428215

Vancouver

McLoone JK, Sansom-Daly UM, Paglia A, Chia J, Larsen HB, Fern LA o.a. A Scoping Review Exploring Access to Survivorship Care for Childhood, Adolescent, and Young Adult Cancer Survivors: How Can We Optimize Care Pathways? Adolescent health, medicine and therapeutics. 2023;14:153-174. https://doi.org/10.2147/AHMT.S428215

Author

McLoone, Jordana K ; Sansom-Daly, Ursula M ; Paglia, Alexia ; Chia, Jessica ; Larsen, Hanne Bækgaard ; Fern, Lorna A ; Cohn, Richard J ; Signorelli, Christina . / A Scoping Review Exploring Access to Survivorship Care for Childhood, Adolescent, and Young Adult Cancer Survivors : How Can We Optimize Care Pathways?. I: Adolescent health, medicine and therapeutics. 2023 ; Bind 14. s. 153-174.

Bibtex

@article{e62ecc92f4624ba7b3e5730146a66c1c,
title = "A Scoping Review Exploring Access to Survivorship Care for Childhood, Adolescent, and Young Adult Cancer Survivors: How Can We Optimize Care Pathways?",
abstract = "Childhood, adolescent, and young adult (CAYA) cancer survivors are at risk of developing late effects associated with their cancer and its treatment. Survivors' engagement with recommended follow-up care to minimize these risks is suboptimal, with many barriers commonly reported. This scoping review aims to summarize the barriers to accessing follow-up care, using the dimensions of Levesque's framework for accessing healthcare. We retrieved quantitative studies addressing barriers and facilitators to accessing survivorship care in CAYA survivors from PubMed, EMBASE and CINAHL. Data was categorized into the five healthcare access dimensions outlined in Levesque's framework: i) approachability, ii) acceptability, iii) availability and accommodation, iv) affordability, and v) appropriateness. We identified 27 quantitative studies in our review. Commonly reported barriers to accessing care included a lack of survivor and provider knowledge of cancer survivorship, poor health beliefs, low personal salience to engage in follow-up care, high out-of-pocket costs and survivors living long distances from clinical services. Many studies reported increased barriers to care during the transition from paediatric to adult-oriented healthcare services, including a lack of developmentally appropriate services, lack of appointment reminders, and a poorly defined transition process. Healthcare-related self-efficacy was identified as an important facilitator to accessing follow-up care. The transition from pediatric to adult-oriented healthcare services is a challenging time for childhood, adolescent, and young adult cancer survivors. Optimizing CAYAs' ability to access high-quality survivorship care thus requires careful consideration of the quality and acceptability of services, alongside financial and physical/practical barriers (eg distance from available services, appointment-booking mechanisms). Levesque's model highlighted several areas where evidence is well established (eg financial barriers) or lacking (eg factors associated with engagement in follow-up care) which are useful to understand barriers and facilitators that impact access to survivorship for CAYA cancer survivors, as well as guiding areas for further evaluation.",
author = "McLoone, {Jordana K} and Sansom-Daly, {Ursula M} and Alexia Paglia and Jessica Chia and Larsen, {Hanne B{\ae}kgaard} and Fern, {Lorna A} and Cohn, {Richard J} and Christina Signorelli",
note = "{\textcopyright} 2023 McLoone et al.",
year = "2023",
doi = "10.2147/AHMT.S428215",
language = "English",
volume = "14",
pages = "153--174",
journal = "Adolescent health, medicine and therapeutics",
issn = "1179-318X",
publisher = "Dove Medical Press Ltd",

}

RIS

TY - JOUR

T1 - A Scoping Review Exploring Access to Survivorship Care for Childhood, Adolescent, and Young Adult Cancer Survivors

T2 - How Can We Optimize Care Pathways?

AU - McLoone, Jordana K

AU - Sansom-Daly, Ursula M

AU - Paglia, Alexia

AU - Chia, Jessica

AU - Larsen, Hanne Bækgaard

AU - Fern, Lorna A

AU - Cohn, Richard J

AU - Signorelli, Christina

N1 - © 2023 McLoone et al.

PY - 2023

Y1 - 2023

N2 - Childhood, adolescent, and young adult (CAYA) cancer survivors are at risk of developing late effects associated with their cancer and its treatment. Survivors' engagement with recommended follow-up care to minimize these risks is suboptimal, with many barriers commonly reported. This scoping review aims to summarize the barriers to accessing follow-up care, using the dimensions of Levesque's framework for accessing healthcare. We retrieved quantitative studies addressing barriers and facilitators to accessing survivorship care in CAYA survivors from PubMed, EMBASE and CINAHL. Data was categorized into the five healthcare access dimensions outlined in Levesque's framework: i) approachability, ii) acceptability, iii) availability and accommodation, iv) affordability, and v) appropriateness. We identified 27 quantitative studies in our review. Commonly reported barriers to accessing care included a lack of survivor and provider knowledge of cancer survivorship, poor health beliefs, low personal salience to engage in follow-up care, high out-of-pocket costs and survivors living long distances from clinical services. Many studies reported increased barriers to care during the transition from paediatric to adult-oriented healthcare services, including a lack of developmentally appropriate services, lack of appointment reminders, and a poorly defined transition process. Healthcare-related self-efficacy was identified as an important facilitator to accessing follow-up care. The transition from pediatric to adult-oriented healthcare services is a challenging time for childhood, adolescent, and young adult cancer survivors. Optimizing CAYAs' ability to access high-quality survivorship care thus requires careful consideration of the quality and acceptability of services, alongside financial and physical/practical barriers (eg distance from available services, appointment-booking mechanisms). Levesque's model highlighted several areas where evidence is well established (eg financial barriers) or lacking (eg factors associated with engagement in follow-up care) which are useful to understand barriers and facilitators that impact access to survivorship for CAYA cancer survivors, as well as guiding areas for further evaluation.

AB - Childhood, adolescent, and young adult (CAYA) cancer survivors are at risk of developing late effects associated with their cancer and its treatment. Survivors' engagement with recommended follow-up care to minimize these risks is suboptimal, with many barriers commonly reported. This scoping review aims to summarize the barriers to accessing follow-up care, using the dimensions of Levesque's framework for accessing healthcare. We retrieved quantitative studies addressing barriers and facilitators to accessing survivorship care in CAYA survivors from PubMed, EMBASE and CINAHL. Data was categorized into the five healthcare access dimensions outlined in Levesque's framework: i) approachability, ii) acceptability, iii) availability and accommodation, iv) affordability, and v) appropriateness. We identified 27 quantitative studies in our review. Commonly reported barriers to accessing care included a lack of survivor and provider knowledge of cancer survivorship, poor health beliefs, low personal salience to engage in follow-up care, high out-of-pocket costs and survivors living long distances from clinical services. Many studies reported increased barriers to care during the transition from paediatric to adult-oriented healthcare services, including a lack of developmentally appropriate services, lack of appointment reminders, and a poorly defined transition process. Healthcare-related self-efficacy was identified as an important facilitator to accessing follow-up care. The transition from pediatric to adult-oriented healthcare services is a challenging time for childhood, adolescent, and young adult cancer survivors. Optimizing CAYAs' ability to access high-quality survivorship care thus requires careful consideration of the quality and acceptability of services, alongside financial and physical/practical barriers (eg distance from available services, appointment-booking mechanisms). Levesque's model highlighted several areas where evidence is well established (eg financial barriers) or lacking (eg factors associated with engagement in follow-up care) which are useful to understand barriers and facilitators that impact access to survivorship for CAYA cancer survivors, as well as guiding areas for further evaluation.

U2 - 10.2147/AHMT.S428215

DO - 10.2147/AHMT.S428215

M3 - Review

C2 - 37753163

VL - 14

SP - 153

EP - 174

JO - Adolescent health, medicine and therapeutics

JF - Adolescent health, medicine and therapeutics

SN - 1179-318X

ER -

ID: 393773370